QuantumScape's third-quarter 2022 Form 10-Q, filed with the SEC on October 28, 2022, holds two facts that have to be read together. First, the balance sheet shows $298.0 million in cash and cash equivalents as of September 30, 2022 — down from the prior year, as a development-stage company burns through its treasury. Second, the filing describes a complete B-sample cell, defined as a functional, complete battery-cell prototype produced from its pre-pilot or sample production line, as a milestone that matters to its commercial path.

Put plainly, the B-sample is the gate. A development-stage cell maker does not earn revenue by publishing test data; it earns it by getting validated cells into the hands of automakers who then commit to programs. The 10-Q's framing of the B-sample milestone is the company telling you where the next real value inflection sits — and, implicitly, where the risk concentrates.

Against that gate sits the cash. At $298.0 million, QuantumScape still has a meaningful cushion, but the year-over-year decline from the prior period is exactly what a pre-revenue runway looks like in motion. The relevant arithmetic for a markets reader is the same it has always been here: cash on hand divided by quarterly burn equals quarters of independence before the company must raise again or hit a milestone that unlocks partner capital.

The strategic tension the filing exposes is timing risk. The B-sample milestone and the cash runway are racing each other. If validated cells arrive while the cushion is still healthy, the company negotiates from strength; if the runway thins first, any raise comes on worse terms. The 10-Q lays out both sides of that race without, of course, calling the winner.

What this document does not contain — and cannot, given the stage — is a unit-economics story. There is no cost-per-kWh to model because there is no production at scale. The B-sample is about proving the cell works and is manufacturable enough to validate, not about proving it pencils. That economic question lives several milestones downstream.

We analyze, we don't advise. For QuantumScape in late 2022, the scorecard reduces to two moving lines: a validation milestone the filing names as gating, and a cash balance steadily working toward zero. The investment case is entirely about which line moves faster.

Figures from the filing on sec.gov, indexed by EdgarBeast.